Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study.
Soo Jin ParkGa Won YimHaerin PaikNa-Ra LeeSeungmee LeeMaria LeeHee Seung KimPublished in: Journal of gynecologic oncology (2021)
ClinicalTrials.gov Identifier: NCT04201561.